A detailed history of Millrace Asset Group, Inc. transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Millrace Asset Group, Inc. holds 4,611 shares of TMDX stock, worth $284,498. This represents 0.74% of its overall portfolio holdings.

Number of Shares
4,611
Previous 4,668 1.22%
Holding current value
$284,498
Previous $703,000 2.99%
% of portfolio
0.74%
Previous 0.68%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$135.68 - $176.11 $7,733 - $10,038
-57 Reduced 1.22%
4,611 $724,000
Q2 2024

Aug 12, 2024

SELL
$72.62 - $150.62 $1.29 Million - $2.68 Million
-17,760 Reduced 79.19%
4,668 $703,000
Q1 2024

May 13, 2024

BUY
$70.86 - $89.93 $1.01 Million - $1.29 Million
14,305 Added 176.1%
22,428 $1.66 Million
Q4 2023

Feb 12, 2024

SELL
$36.74 - $81.08 $138,105 - $304,779
-3,759 Reduced 31.64%
8,123 $641,000
Q3 2023

Nov 13, 2023

SELL
$53.47 - $96.07 $104,694 - $188,105
-1,958 Reduced 14.15%
11,882 $651,000
Q2 2023

Aug 14, 2023

BUY
$66.23 - $88.73 $35,168 - $47,115
531 Added 3.99%
13,840 $1.16 Million
Q1 2023

May 11, 2023

SELL
$53.63 - $82.33 $248,360 - $381,270
-4,631 Reduced 25.81%
13,309 $1.01 Million
Q4 2022

Feb 13, 2023

SELL
$39.08 - $64.29 $92,932 - $152,881
-2,378 Reduced 11.7%
17,940 $1.11 Million
Q3 2022

Oct 31, 2022

SELL
$31.56 - $55.75 $202,867 - $358,361
-6,428 Reduced 24.03%
20,318 $848,000
Q2 2022

Jul 28, 2022

SELL
$20.56 - $32.15 $956,266 - $1.5 Million
-46,511 Reduced 63.49%
26,746 $841,000
Q1 2022

May 04, 2022

SELL
$12.58 - $26.94 $131,662 - $281,954
-10,466 Reduced 12.5%
73,257 $1.97 Million
Q4 2021

Feb 14, 2022

BUY
$19.16 - $32.68 $1.6 Million - $2.74 Million
83,723 New
83,723 $1.6 Million

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $1.96B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Millrace Asset Group, Inc. Portfolio

Follow Millrace Asset Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millrace Asset Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Millrace Asset Group, Inc. with notifications on news.